Cullinan Therapeutics, Inc.
CGEM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$50,610 | -$70,055 | -$48,501 | -$47,647 |
| Dep. & Amort. | $79 | $77 | $76 | $77 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $9,887 | $9,374 | $9,634 |
| Change in WC | $5,545 | $4,188 | -$1,793 | $4,821 |
| Other Non-Cash | $8,109 | -$1,706 | -$2,311 | -$3,511 |
| Operating Cash Flow | -$36,877 | -$57,609 | -$43,155 | -$36,626 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$12,570 | -$78,526 | -$125,840 | -$168,036 |
| Inv. Sales/Matur. | $80,000 | $131,927 | $162,645 | $184,000 |
| Other Inv. Act. | -$38 | $0 | $0 | $0 |
| Investing Cash Flow | $67,392 | $53,401 | $36,805 | $15,964 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $1,582 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $373 | $0 | $0 |
| Financing Cash Flow | $0 | $373 | $0 | $1,582 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $30,515 | -$3,835 | -$6,350 | -$19,080 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $72,820 | $76,655 | $83,005 | $102,085 |
| End Cash | $103,335 | $72,820 | $76,655 | $83,005 |
| Free Cash Flow | $0 | -$57,609 | -$43,155 | -$36,626 |